Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIME regimen in metastatic breast cancer
NCT00006032Phase 2Terminated
- Sponsor
- Moffitt Cancer Center
- Start
- Mar 2000
- Primary completion
- Apr 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan in breast cancer, sponsored by Moffitt Cancer Center. Started Mar 2000; status: terminated.
02
Drugs
topotecan
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00006032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006032.